CClinicalTrials.gg
RecruitingNCT07333989Updated Mar 20, 2026

Effect of Biofeedback Activation on Balance in Osteoporotic Elderly

An interventional study of Electromyographic (EMG) biofeedback and Balance training in Balance Problems and Elderly (People Aged 65 or More), sponsored by Mohamed Said Alsafy Alhamrawy. Recruiting at 1 site in Egypt. Open to participants aged 65 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-03-20.

Sponsored by Mohamed Said Alsafy Alhamrawy · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Apr 2026, 6 months ago, but the record still lists the study as recruiting.
  • Started Jan 2026; still recruiting 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
65 Years to 75 Years
Sex
All
01

Study summary

This study aimed to investigate the effect of gluteus medius activation using electromyography (EMG) biofeedback combined with balance training on balance, physical performance, gluteus medius muscle activity, and quality of life in osteoporotic elderly patients.

02

Conditions studied

  • Balance Problems
  • Elderly (People Aged 65 or More)

Browse trials for

Keywords

  • Osteoporosis
  • Elderly
  • Balance training
  • Gluteus medius
  • Electromyography biofeedback
  • Quality of life
  • performance.
03

In context

Osteoporosis

1,640 studies on the registry are indexed under Osteoporosis; 212 are open to participants now.

This study's planned enrollment of 60 is below the median of 95 across 1,133 interventional studies indexed under Osteoporosis.

Browse Osteoporosis studies →

Lead sponsor

This is the only study on the registry with Mohamed Said Alsafy Alhamrawy as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • All patients included in this study met the following criteria:

    1. Sixty patients of both sexes were diagnosed with osteoporosis confirmed by bone density test through Dual-energy X-ray absorptiometry (DEXA) scan (A T-score equal to or less than - 2.5) (Sheu and Diamond, 2016).
    2. Their age ranged between 65 - 75 years.
    3. Their BMI ranged between 25 - 29.9 kg/m2.
    4. They had good mentality and cognitive function.

Exclusion criteria

Exclusion Criteria:

  • The potential patients were excluded if they have one of the following criteria:

    1. Patients with endocrine disorders likely to be related to metabolic bone disease, such as premature ovarian failure, hypogonadism, untreated hyperthyroidism, hyperparathyroidism, adrenal insufficiency or Cushing's syndrome.
    2. Patients with active contagious skin conditions.
    3. Patients with implant devices such as pacemaker or electrical prosthesis.
    4. Any cardiopulmonary disorders.
    5. Any neuromuscular disorders.
    6. Any acute viral infection.
    7. Patients with ascites or end stage liver or kidney failure.
    8. Leg discrepancy.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Gluteus medius isometric strengthening using EMG with traditional balance training

    received 30 minutes of traditional balance training (functional strength, static and dynamic balance, and gait training) followed by 30 minutes of gluteus medius isometric strengthening using EMG biofeedback, three times per week, for four consecutive weeks.

    Device: Electromyographic (EMG) biofeedback

  • Active comparator
    Traditional balance training only

    received balance training alone with the same frequency and duration.

    Other: Balance training

Interventions

  • DeviceElectromyographic (EMG) biofeedback

    a physical therapy intervention that uses auditory and visual feedback to control the contraction or relaxation of muscles. Repeated biofeedback training can induce motor learning of muscles. Biofeedback enhances the function of pelvic floor muscles by enhancing the force generation, correct timing, and coordination of the pelvic floor muscles. Electromyography Biofeedback is considered as a behavioural therapy training modality

  • OtherBalance training

    functional strength, static and dynamic balance, and gait training

06

What researchers measure

Primary outcomes

  1. Balance

    balance of osteoporotic elderly patients (antero-posterior, medio-lateral, and overall stability indices; Berg Balance Scale)

    Time frame: Base line before treatment, then one month after treatment

Secondary outcomes

  1. gluteus medius activity

    Assessment of gluteus medius strength by hand-held dynamometer

    Time frame: Base line before treatment and reassessment after one month of treatment

07

Study locations

1 of 1 sites recruiting
  • General Hospital Abouhms
    Abū Ḩummuş, 045, Egypt
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07333989
Lead sponsor
Mohamed Said Alsafy Alhamrawy
Responsible party
Mohamed Said Alsafy Alhamrawy (Doctor, Cairo University) — Sponsor-investigator
First posted
Jan 12, 2026
Start date
Jan 2, 2026
Primary completion
Apr 5, 2026 (estimated)
Completion
May 1, 2026 (estimated)
Last update
Mar 20, 2026

Study contacts

Mohamed Alhamrawy
Contact
Mohamedalhamrawy333@gmail.com
+201013132649

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion